Forus raised a $150M Series C to expand its AI-powered prescription platform across medical specialties and grow its technical and go-to-market teams.
- Amount
- $150M
- Stage
- Series C
- Announced
- 8 September 2026
- Lead
- Bain Capital Ventures
- Other investors
- Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Avra, Human Capital, Neo, Vast Ventures, SV Angel
- Use of funds
- Deepening the platform with more AI agents and clinical models, expanding to all medical specialties and sites of care, and growing technical and go-to-market teams.
- Valuation
- $3B
- Checked
- Amount and date matched across 3 press sources